Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.76 USD | -2.59% | -14.32% | +38.25% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.25% | 4.8B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.46% | 21.97B | |
-4.41% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Transcript : NantKwest, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05